| Clinician’s guide to prevention and treatment of osteoporosis F Cosman, SJ de Beur, MS LeBoff, EM Lewiecki, B Tanner, S Randall, ... Osteoporosis international 25, 2359-2381, 2014 | 3906 | 2014 |
| Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature AL Folpe, JC Fanburg-Smith, SD Billings, M Bisceglia, F Bertoni, JY Cho, ... The American journal of surgical pathology 28 (1), 1-30, 2004 | 697 | 2004 |
| The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group ES Siris, R Adler, J Bilezikian, M Bolognese, B Dawson-Hughes, ... Osteoporosis international 25, 1439-1443, 2014 | 679 | 2014 |
| A clinician's guide to X‐linked hypophosphatemia TO Carpenter, EA Imel, IA Holm, SM Jan de Beur, KL Insogna Journal of Bone and Mineral Research 26 (7), 1381-1388, 2011 | 661 | 2011 |
| Primer on the metabolic bone diseases and disorders of mineral metabolism CJ Rosen John Wiley & Sons, 2009 | 634 | 2009 |
| FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate AE Bowe, R Finnegan, SMJ de Beur, J Cho, MA Levine, R Kumar, ... Biochemical and biophysical research communications 284 (4), 977-981, 2001 | 385 | 2001 |
| Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent T Berndt, TA Craig, AE Bowe, J Vassiliadis, D Reczek, R Finnegan, ... The Journal of clinical investigation 112 (5), 785-794, 2003 | 327 | 2003 |
| Paternally Inherited Inactivating Mutations of the GNAS1 Gene in Progressive Osseous Heteroplasia EM Shore, J Ahn, SJ De Beur, M Li, M Xu, RJMK Gardner, MA Zasloff, ... New England Journal of Medicine 346 (2), 99-106, 2002 | 316 | 2002 |
| A randomized, double‐blind, placebo‐controlled, phase 3 trial evaluating the efficacy of burosumab, an anti‐FGF23 antibody, in adults with X‐linked hypophosphatemia: week 24 … KL Insogna, K Briot, EA Imel, P Kamenický, MD Ruppe, AA Portale, ... Journal of Bone and Mineral Research 33 (8), 1383-1393, 2018 | 269 | 2018 |
| Tumor-induced osteomalacia SMJ De Beur Jama 294 (10), 1260-1267, 2005 | 264 | 2005 |
| Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism SMJ De Beur, RB Finnegan, J Vassiliadis, B Cook, D Barberio, S Estes, ... Journal of Bone and Mineral Research 17 (6), 1102-1110, 2002 | 247 | 2002 |
| Localisation of mesenchymal tumours by somatostatin receptor imaging SMJ de Beur, EA Streeten, AC Civelek, EF McCarthy, L Uribe, SJ Marx, ... The Lancet 359 (9308), 761-763, 2002 | 233 | 2002 |
| Injury-activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling M Wan, C Li, G Zhen, K Jiao, W He, X Jia, W Wang, C Shi, Q Xing, ... Stem cells 30 (11), 2498-2511, 2012 | 176 | 2012 |
| Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance EL Germain-Lee, J Groman, JL Crane, SM Jan de Beur, MA Levine The Journal of Clinical Endocrinology & Metabolism 88 (9), 4059-4069, 2003 | 166 | 2003 |
| Goal‐directed treatment for osteoporosis: a progress report from the ASBMR‐NOF Working Group on Goal‐Directed Treatment for Osteoporosis SR Cummings, F Cosman, EM Lewiecki, JT Schousboe, DC Bauer, ... Journal of Bone and Mineral Research 32 (1), 3-10, 2017 | 148 | 2017 |
| Molecular pathogenesis of hypophosphatemic rickets SM Jan De Beur, MA Levine The Journal of Clinical Endocrinology & Metabolism 87 (6), 2467-2473, 2002 | 128 | 2002 |
| Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo … AA Portale, TO Carpenter, ML Brandi, K Briot, HII Cheong, M Cohen-Solal, ... Calcified tissue international 105, 271-284, 2019 | 127 | 2019 |
| Postoperative hypoparathyroidism: medical and surgical therapeutic options V Walker Harris, S Jan De Beur Thyroid 19 (9), 967-973, 2009 | 126 | 2009 |
| Deficiency of the α‐subunit of the stimulatory G protein and severe extraskeletal ossification MC Eddy, SM Jan de beur, SM Yandow, WH McAlister, EM Shore, ... Journal of Bone and Mineral Research 15 (11), 2074-2083, 2000 | 119 | 2000 |
| Burosumab for the treatment of tumor‐induced osteomalacia SM Jan de Beur, PD Miller, TJ Weber, M Peacock, K Insogna, R Kumar, ... Journal of Bone and Mineral Research 36 (4), 627-635, 2020 | 116 | 2020 |
Michael A. Levine, M.D.Professor Emeritus of Pediatrics and Medicine, University of PennsylvaniaDirección de correo verificada de chop.edu
